OFFICIAL PUBLICATION OF

by its subsidiary APPco

GuildLink drives MedAdvisor revenue growth

Nicholas O’Donoghue 24/01/2023

Medication management platform, MedAdvisor’s acquisition of GuildLink is bearing fruit with the former Guild Group subsidiary making a significant contribution to the firm’s revenue growth. Announcing its 2023 financial year second quarter results (to 31 December 2022) to the Australian Securities Exchange (ASX), MedAdvisor CEO, Rick Ratliff, revealed global revenue was up 89.9 per

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

GuildLink drives MedAdvisor revenue growth

Previous New HCF deal promises cheaper Ramsay pharmacy prices

Next Technology lagging on pharmacists’ needs

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous New HCF deal promises cheaper Ramsay pharmacy prices

Next Technology lagging on pharmacists’ needs

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.